Daniel Lopes de Menezes (Daniel L Menezes)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Smoking Cessation

Patient Reported

Acute Myeloid Leukemia

Mesenchymal Stem Cells

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Farhad Ravandi, Hartmut Döhner, Andrew H Wei, Pau Montesinos, Michael Pfeilstöcker, Cristina Papayannidis, Yinzhi Lai, Kefeng Wang, Wendy L See, Daniel Lopes de Menezes, Erica Petrlik, Thomas Prebet, Gail J Roboz
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001. British journal of haematology (2023)
Daniel Lopes de Menezes, Wendy L See, Alberto Risueño, Kao Tai Tsai, Jae K Lee, Johnny Ma, Rida Khan, Thomas Prebet, Barry Skikne, C L Beach, Anjan Thakurta, Anita Gandhi
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trial. British journal of haematology (2023)
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian Fox
Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy. Leukemia (2022)